Winston-Salem, NC, United States of America

Otis Clinton Attucks

This inventor holds 13 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Vtv Therapeutics LLC, High Point Pharmaceuticals, LLC. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Otis Clinton Attucks. Retrieved from https://idiyas.com/inventor/otis-clinton-attucks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 47(Granted Patents)

Company Filing History:

High Point Pharmaceuticals, LLC

patents

Years Active: 2014-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12091407 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2024-09-17),

2. 11649230 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2023-05-16),

3. 11130753 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2021-09-28),

4. 10898475 - Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof (2021-01-26),

5. 10889580 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2021-01-12),

6. 10570126 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2020-02-25),

7. 10463652 - Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof (2019-11-05),

8. 10287284 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2019-05-14),

9. 10172840 - Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof (2019-01-08),

10. 10030011 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2018-07-24),

11. 9707239 - Compounds that modulate oxidative stress (2017-07-18),

12. 9447468 - Compounds that modulate oxidative stress (2016-09-20),

13. 8759535 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2014-06-24),

Title: Otis Clinton Attucks: Innovator in Pharmaceutical Chemistry

Introduction

Otis Clinton Attucks is a notable inventor based in Winston-Salem, NC (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 13 patents, showcasing his innovative approach to developing new pharmaceutical compositions and methods.

Latest Patents

Attucks' latest patents focus on substituted fused imidazole derivatives, which are significant in the treatment of renal diseases. These patents detail methods of preparation and pharmaceutical compositions that may control the activity or the amount of heme-oxygenase, providing new avenues for medical treatment.

Career Highlights

Throughout his career, Attucks has worked with prominent companies such as VTV Therapeutics LLC and High Point Pharmaceuticals, LLC. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Attucks has collaborated with talented individuals in his field, including Jareer Nabeel Kassis and Matthew J Kostura. These partnerships have fostered innovation and enhanced the research and development processes in pharmaceutical chemistry.

Conclusion

Otis Clinton Attucks is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of renal diseases. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.